| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intravenous-guinea pig LDLo 200 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 101, Pg. 81, 1955.
intraperitoneal-mouse LD50 600 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 106, Pg. 341, 1952.
intravenous-mouse LD50 75 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 106, Pg. 341, 1952.
oral-mouse LD50 4200 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64(4), Pg. 140S, 1968.
intraperitoneal-rat LD50 1350 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64(4), Pg. 140S, 1968.
oral-rat LD50 1240 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64(4), Pg. 140S, 1968.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 2070 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64(4), Pg. 140S, 1968.
subcutaneous-rat LD50 350 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64(4), Pg. 140S, 1968.
|
| Inhalation Toxicity: |
|
Not determined
|